{"id":1022996,"date":"2026-11-20T13:42:12","date_gmt":"2026-11-20T18:42:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/"},"modified":"2026-11-20T13:42:12","modified_gmt":"2026-11-20T18:42:12","slug":"abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/","title":{"rendered":"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">ATLANTA, Nov.  20, 2026  (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether Abivax S.A.\u00a0(\u201cAbivax\u201d or the \u201cCompany\u201d) (NASDAQ: ABVX) complied with federal securities laws.\u00a0On November 18, 2026, <em>Scorpion Capital<\/em> published a report alleging, among other things, that obefazimod exhibits high lipophilicity, \u201cviolates one of the industry\u2019s most basic screens for oral drug viability\u201d and further alleges that the drug\u2019s properties \u201cresembles the signature of persistent organic pollutants (POPs) and certain agrochemicals.\u201d On this news, the price of the Company\u2019s stock dropped.\u00a0<\/p>\n<p align=\"justify\">If you purchased Abivax stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KiZ4uL095yMh8b_gZPfHMDhWgR_IXTpmxVvVYSatg1xl_kwj0w3dAw6IerTDsSuE_TFEjKp1M5gjFu_ZkkFtyfg88Q83BV7NKSPssWYPh-k=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a> or Joshua Karr, Esq. at\u202f<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vmF5N6hWoYElL0IeM21VEMjzh1hSTBwEzgCWettfUYfi_G7fFpO81sf26ZKeK6_BCItF0EU_yHzTeWi4uSOeNEmFuzvA2TSn8JyTIthClYE=\" rel=\"nofollow\" target=\"_blank\"><u>jkarr@holzerlaw.com<\/u><\/a>, call our toll-free number at (888) 508-6832, or visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TlE2inSmXK_UutGUDJ_70JvwI3UMJnVv1877Z1NqAXig_C_wP1osySEeKQWimLfsMs_5HEsH0ieCJCa9ythrFYzopGbkmYb5XtmDKWGXOh0oDfVYbrNE4oV7p3I5om-g\" rel=\"nofollow\" target=\"_blank\">www.holzerlaw.com\/case\/abivax\/<\/a> to discuss your legal rights.<\/p>\n<p align=\"justify\">Holzer &amp; Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, 2023 and 2025, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer &amp; Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.\u202fMore information about the firm is available through its website, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=TlE2inSmXK_UutGUDJ_70GHfOq4HjqsQxExqn_s-W5rZc7KKHiwOeUznADP3PYS_R-ntKwPt9O75tAYpVaT6JiYG3_YEgY9mCWksFI8s-A4=\" rel=\"nofollow\" target=\"_blank\"><u>www.holzerlaw.com<\/u><\/a>,\u202fand upon request from the firm. Holzer &amp; Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.<\/p>\n<p align=\"justify\">CONTACT:<br \/>Corey Holzer, Esq.<br \/>(888) 508-6832 (toll-free) <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KiZ4uL095yMh8b_gZPfHMDhWgR_IXTpmxVvVYSatg1wF7NniRk8mwPv-r2r5KGWzzJwaFUxG4wFCx7KO-LUKBiAc5ljGiEi4ibcM8KcCSCY=\" rel=\"nofollow\" target=\"_blank\">cholzer@holzerlaw.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MmEzYjUxMmItYWZjYy00NGRkLTlmNjctNTQ5NzU5OWQ5YjRlLTExOTIzMzYtMjAyNi0xMS0yMC1lbg==\/tiny\/Holzer-Holzer.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ATLANTA, Nov. 20, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether Abivax S.A.\u00a0(\u201cAbivax\u201d or the \u201cCompany\u201d) (NASDAQ: ABVX) complied with federal securities laws.\u00a0On November 18, 2026, Scorpion Capital published a report alleging, among other things, that obefazimod exhibits high lipophilicity, \u201cviolates one of the industry\u2019s most basic screens for oral drug viability\u201d and further alleges that the drug\u2019s properties \u201cresembles the signature of persistent organic pollutants (POPs) and certain agrochemicals.\u201d On this news, the price of the Company\u2019s stock dropped.\u00a0 If you purchased Abivax stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at\u202fjkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1022996","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"ATLANTA, Nov. 20, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether Abivax S.A.\u00a0(\u201cAbivax\u201d or the \u201cCompany\u201d) (NASDAQ: ABVX) complied with federal securities laws.\u00a0On November 18, 2026, Scorpion Capital published a report alleging, among other things, that obefazimod exhibits high lipophilicity, \u201cviolates one of the industry\u2019s most basic screens for oral drug viability\u201d and further alleges that the drug\u2019s properties \u201cresembles the signature of persistent organic pollutants (POPs) and certain agrochemicals.\u201d On this news, the price of the Company\u2019s stock dropped.\u00a0 If you purchased Abivax stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at\u202fjkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at &hellip; Continue reading &quot;ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-20T18:42:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC\",\"datePublished\":\"2026-11-20T18:42:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/\"},\"wordCount\":265,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/\",\"name\":\"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=\",\"datePublished\":\"2026-11-20T18:42:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/","og_locale":"en_US","og_type":"article","og_title":"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","og_description":"ATLANTA, Nov. 20, 2026 (GLOBE NEWSWIRE) &#8212; Holzer &amp; Holzer, LLC is investigating whether Abivax S.A.\u00a0(\u201cAbivax\u201d or the \u201cCompany\u201d) (NASDAQ: ABVX) complied with federal securities laws.\u00a0On November 18, 2026, Scorpion Capital published a report alleging, among other things, that obefazimod exhibits high lipophilicity, \u201cviolates one of the industry\u2019s most basic screens for oral drug viability\u201d and further alleges that the drug\u2019s properties \u201cresembles the signature of persistent organic pollutants (POPs) and certain agrochemicals.\u201d On this news, the price of the Company\u2019s stock dropped.\u00a0 If you purchased Abivax stock and suffered\u202fa\u202floss on that investment, you are encouraged to contact Corey Holzer, Esq. at cholzer@holzerlaw.com or Joshua Karr, Esq. at\u202fjkarr@holzerlaw.com, call our toll-free number at (888) 508-6832, or visit our website at &hellip; Continue reading \"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-20T18:42:12+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC","datePublished":"2026-11-20T18:42:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/"},"wordCount":265,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/","name":"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=","datePublished":"2026-11-20T18:42:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg4MjM1MiM3OTc5MDg0IzIxODA3Njc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/abvx-investor-alert-investigation-of-abivax-s-a-announced-by-holzer-holzer-llc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ABVX INVESTOR ALERT: Investigation of Abivax S.A.\u00a0Announced by Holzer &amp; Holzer, LLC"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1022996"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1022996\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1022996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1022996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1022996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}